Denise Carter
2023
In 2023, Denise Carter earned a total compensation of $1.1M as Chief Operating Officer at Quoin Pharmaceuticals, Ltd., a 41% decrease compared to previous year.
Compensation breakdown
| Bonus | $240,900 |
|---|---|
| Option Awards | $292,266 |
| Salary | $481,800 |
| Other | $56,000 |
| Total | $1,070,966 |
Carter received $481.8K in salary, accounting for 45% of the total pay in 2023.
Carter also received $240.9K in bonus, $292.3K in option awards and $56K in other compensation.
Rankings
In 2023, Denise Carter's compensation ranked 1,095th out of 2,745 executives tracked by ExecPay. In other words, Carter earned more than 60.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,095 out of 2,745 | 60th |
Division Manufacturing | 656 out of 1,502 | 56th |
Major group Chemicals And Allied Products | 442 out of 846 | 48th |
Industry group Drugs | 431 out of 812 | 47th |
Industry Pharmaceutical Preparations | 293 out of 581 | 50th |
Source: SEC filing on October 24, 2024.
Carter's colleagues
We found two more compensation records of executives who worked with Denise Carter at Quoin Pharmaceuticals, Ltd. in 2023.